C-Phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages

Vadiraja, 1998, Hepatoprotective effect of C-Phycocaynin: protection for carbon tetrachloride and R-(+)-pulegone mediated hepatotoxicity in rats, Biochem. Biophys. Res. Commun., 249, 428, 10.1006/bbrc.1998.9149

Bhat, 2000, C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro, Biochem. Biophys. Res. Commun., 275, 20, 10.1006/bbrc.2000.3270

Remirez, 1999, Effect of Phycocyanin in zymosan-induced arthritis in mice-Phycocyanin as an antiarthritic compound, Drug. Dev. Res., 48, 70, 10.1002/(SICI)1098-2299(199910)48:2<70::AID-DDR4>3.0.CO;2-N

Romay, 2000, Effects of phycocyanin extract on prostaglandin E2 levels in mouse ear inflammation test, Arzneimittelforschung, 50, 1106

Romay, 1998, Antioxidant and anti-inflammatory properties of C-Phycocyanin from blue green algae, Inflamm. Res., 47, 36, 10.1007/s000110050256

Reddy, 2000, Selective inhibition of cyclooxygenase-2 by C-Phycocyanin, a biliprotein from Spirulina platensis, Biochem. Biophys. Res. Commun., 277, 599, 10.1006/bbrc.2000.3725

Vane, 1987, Inflammation and the mechanism of action of anti-inflammatory drugs, FASEB J., 1, 89, 10.1096/fasebj.1.2.3111928

Smith, 1992, Prostanoid biosynthesis and mechanisms of action, Am. J. Physiol., 263, F181

Whittle, 1980, Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa, Nature, 284, 271, 10.1038/284271a0

Mocanda, 1976, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation, Nature, 263, 663, 10.1038/263663a0

Kujubu, 1991, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandinsynthase/cyclooxygenase homologue, J. Biol. Chem., 266, 12866, 10.1016/S0021-9258(18)98774-0

Xie, 1991, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing, Proc. Natl. Acad. Sci. USA, 88, 2692, 10.1073/pnas.88.7.2692

Dannenberg, 2001, Cyclo-oxygenase 2: a pharmaceutical target for the prevention of cancer, Lancet Oncol., 2, 544, 10.1016/S1470-2045(01)00488-0

DuBois, 1996, Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors, Gastroenterology, 110, 1259, 10.1053/gast.1996.v110.pm8613017

Campling, 1988, Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells, Leukemia Res., 12, 823, 10.1016/0145-2126(88)90036-7

Nicoletti, 1991, Rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry, J. Immunol. Methods, 139, 271, 10.1016/0022-1759(91)90198-O

Shah, 1996, Different cleavage pattern of poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells, Biochem. Biophys. Res. Commun., 229, 838, 10.1006/bbrc.1996.1889

Liu, 1998, NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells, Cancer Res., 58, 4245

Sheng, 1998, Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells, Cancer Res., 58, 362

Lui, 1996, Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c, Cell, 86, 147, 10.1016/S0092-8674(00)80085-9

Martinou, 2000, Cytochrome c release from mitochondria: all or nothing, Nat. Cell Biol., 2, E41, 10.1038/35004069

Joy, 1997, Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2, J. Biol. Chem., 272, 25693, 10.1074/jbc.272.41.25693

DeWitt, 1991, Prostaglandin endoperoxide synthase: regulation of enzyme expression, Biochim. Biophys. Acta, 1083, 121, 10.1016/0005-2760(91)90032-D

Smith, 1991, Prostaglandin endoperoxide synthase: structure and catalysis, Biochim. Biophys. Acta, 1083, 1, 10.1016/0005-2760(91)90119-3

Lee, 1992, Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide, J. Biol. Chem., 267, 25934, 10.1016/S0021-9258(18)35698-9

Kune, 1988, Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study, Cancer Res., 48, 4399

Giovannucci, 1994, Aspirin use and the risk for colorectal cancer and adenoma in male health professionals, Ann. Intern. Med., 121, 241, 10.7326/0003-4819-121-4-199408150-00001

Gupta, 1998, Aspirin, NSAIDs and colon cancer prevention: mechanisms?, Gastroenterology, 114, 1095, 10.1016/S0016-5085(98)70330-0

Hall, 1994, Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis, J. Cell Sci., 107, 3569, 10.1242/jcs.107.12.3569

Bedi, 1995, Inhibition of apoptosis during development of colorectal cancer, Cancer Res., 55, 1811

Fournier, 2000, COX-2 and colon cancer: potential targets for chemoprevention, J. Cell. Biochem., 77, 97, 10.1002/(SICI)1097-4644(2000)77:34+<97::AID-JCB16>3.0.CO;2-Z

Kroemer, 1997, The proto-oncogene Bcl-2 and its role in regulating apoptosis, Nat. Med., 3, 614, 10.1038/nm0697-614

Reed, 1997, Double identity for proteins of the Bcl-2 family, Nature, 387, 773, 10.1038/42867

Narita, 1998, Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria, Proc. Natl. Acad. Sci. USA, 95, 14681, 10.1073/pnas.95.25.14681

Shimizu, 1998, Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux, Proc. Natl. Acad. Sci. USA, 95, 1455, 10.1073/pnas.95.4.1455

Hsu, 2000, The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2, J. Biol. Chem., 275, 11397, 10.1074/jbc.275.15.11397

Patti, 2002, Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib, Cancer Lett., 180, 13, 10.1016/S0304-3835(02)00003-4

Li, 2001, Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway, Clin. Cancer Res., 7, 1010

Li, 1997, Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade, Cell, 91, 479, 10.1016/S0092-8674(00)80434-1

Lazebnik, 1994, Cleavage of poly(ADP- ribose) polymerase by a proteinase with properties like ICE, Nature, 371, 346, 10.1038/371346a0

Yoshihara, 1974, Inhibition of rat liver Ca+2, Mg+2-dependent endonuclease activity by nicotinamide adenine dinucleotide and poly(adenosine diphosphate ribose) synthetase, Biochem. Biophys. Res. Commun., 59, 658, 10.1016/S0006-291X(74)80030-6

Yoshihara, 1975, Evidence for adenosine diphosphate ribosylation of Ca2+, Mg2+-dependent endonuclease, Proc. Natl. Acad. Sci. USA, 72, 289, 10.1073/pnas.72.1.289

Tanaka, 1984, Mechanism of the inhibition of Ca2+, Mg2+-dependent endonucleases of bull seminal plasma induced by ADP-ribosylation, J. Biol. Chem., 25, 6579, 10.1016/S0021-9258(20)82181-4